Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Salarius Pharmaceuticals Inc SLRX

Healthcare Biotechnology
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing treatments for parties with cancers in need of new treatment options. Its product portfolio includes seclidemstat, an oral novel small molecule inhibitor of the LSD1 enzyme and the Company's lead candidate, which is being studied as a potential treatment for pediatric cancers, sarcomas, and... see more

Recent & Breaking News (NDAQ:SLRX)

Ivy Brain Tumor Center and Salarius Pharmaceuticals Launch Collaborative Partnership to Develop New Cancer Treatment for Glioblastoma

GlobeNewswire August 26, 2019

Salarius Pharmaceuticals CEO Issues Letter to Stockholders

GlobeNewswire August 12, 2019

Salarius Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell

GlobeNewswire July 29, 2019

Salarius Pharmaceuticals Successfully Monetizes Legacy Consumer Product

GlobeNewswire July 24, 2019

Flex Pharma Announces Rights Dividend

Business Wire July 18, 2019

Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting

Business Wire July 12, 2019

Flex Pharma Announces Broker Authority to Vote on Certain Proposals

Business Wire June 25, 2019

Flex Pharma Announces Overwhelming Support to Date for the Proposed Merger with Salarius Pharmaceuticals but More Votes are Needed to Complete the Merger

Business Wire June 17, 2019

Flex Pharma Announces that ISS and Glass Lewis Recommend Shareholders Vote "FOR" All Agenda Items relating to Flex's Strategic Merger with Salarius Pharmaceuticals

Business Wire June 10, 2019

Flex Pharma Reports First Quarter 2019 Financial Results

Business Wire May 1, 2019

Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation

PR Newswire April 5, 2019

Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results

Business Wire March 6, 2019

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flex Pharma, Inc. - FLKS

PR Newswire February 26, 2019

Thinking about buying stock in Advanced Micro Devices, Canopy Growth Corp, Facebook, Flex Pharma or Snap Inc.?

PR Newswire January 7, 2019

Mid-Afternoon Market Update: Dow Surges Over 700 Points; Flex Pharma Shares Spike Higher

Benzinga.com  January 4, 2019

41 Stocks Moving In Friday's Mid-Day Session

Benzinga.com  January 4, 2019

Mid-Day Market Update: Resources Connection Rises Following Q2 Results; Arcus Biosciences Shares Slide

Benzinga.com  January 4, 2019

Flex Pharma Finds A Lifeline In Merger With Oncology Biotech Salarius Pharma

Benzinga.com  January 4, 2019

Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer

Business Wire January 4, 2019

Analysis: Positioning to Benefit within Independence Holding, KVH Industries, Attunity, Flex Pharma, Westinghouse Air Brake Technologies, and Alaska Communications Systems Group — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire November 13, 2018